|
|
| (11 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |
| | |
| | |- bgcolor="LightGrey" |
| | ! |
| | [[Lipoprotein disorders| Lipoprotein Disorders Main Page]] |
| |- | | |- |
| | |
| | colspan="1" style="text-align:center; background:DarkGray" | | | | colspan="1" style="text-align:center; background:DarkGray" | |
|
| |
|
| '''Hyperlipoproteinemia Microchapters''' | | '''Hyperlipoproteinemia Microchapters''' |
| |- bgcolor="LightGrey" | | |- bgcolor="LightGrey" |
| !
| |
|
| |
| |- bgcolor="LightCoral"
| |
| !
| |
| [[Hyperlipoproteinemia|Home]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Hyperlipoproteinemia (patient information)|Patient Information]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Hyperlipoproteinemia overview|Overview]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Hyperlipoproteinemia historical perspective|Historical Perspective]]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="Pink"
| |
| !
| |
| [[Hyperlipoproteinemia classification|Classification]]
| |
| |-
| |
| !
| |
|
| |
|
| |- bgcolor="Pink"
| |
| !
| |
| [[Hyperlipoproteinemia pathophysiology|Pathophysiology]]
| |
| : [[Hyperlipoproteinemia pathophysiology#Genetics of Primary Hyperlipoproteinemia|Genetics]]
| |
| |-
| |
| !
| |
|
| |
|
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia causes|Causes]] | | [[Hypercholesterolemia (patient information)|Hypercholesterolemia Patient Information]] |
| |- | | |- |
| ! | | ! |
| Line 52: |
Line 20: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia differential diagnosis|Differentiating Hyperlipoproteinemia from other Diseases]] | | [[Hypertriglyceridemia (patient information)|Hypertriglyceridemia Patient Information]] |
| |- | | |- |
| ! | | ! |
| Line 58: |
Line 26: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia epidemiology and demographics|Epidemiology and Demographics]] | | [[Hyperlipoproteinemia#Overview|Overview]] |
| |- | | |- |
| ! | | ! |
| Line 64: |
Line 32: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia risk factors|Risk Factors]] | | [[Hyperlipoproteinemia#Classification|Classification]] |
| | :'''[[Familial hyperchylomicronemia]]''' |
| | :'''[[Familial hypercholesterolemia]]''' |
| | :'''[[Familial combined hyperlipidemia]]''' |
| | :'''[[Dysbetalipoproteinemia]]''' |
| | :'''[[Primary hypertriglyceridemia]]''' |
| | :'''[[Mixed hyperlipoproteinemia]]''' |
| |- | | |- |
| ! | | ! |
| Line 70: |
Line 44: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia screening|Screening]] | | [[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]] |
| |- | | |- |
| ! | | ! |
| Line 76: |
Line 50: |
| |- bgcolor="Pink" | | |- bgcolor="Pink" |
| ! | | ! |
| [[Hyperlipoproteinemia natural history, complications and prognosis|Natural History, Complications and Prognosis]] | | [[Hyperlipoproteinemia#Screening|Screening]] |
| |-
| |
| !
| |
| | |
| |- bgcolor="CornFlowerBlue"
| |
| !
| |
| Diagnosis
| |
| |-
| |
| !
| |
| | |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hyperlipoproteinemia history and symptoms|History and Symptoms]]
| |
| |-
| |
| !
| |
| | |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hyperlipoproteinemia physical examination|Physical Examination]]
| |
| |-
| |
| !
| |
| | |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hyperlipoproteinemia laboratory findings|Laboratory Findings]]
| |
| |-
| |
| !
| |
| | |
| |- bgcolor="LightSkyBlue"
| |
| !
| |
| [[Hyperlipoproteinemia other diagnostic studies|Diagnostic Studies]]
| |
| |- | | |- |
| ! | | ! |
| Line 112: |
Line 56: |
| |- bgcolor="CadetBlue" | | |- bgcolor="CadetBlue" |
| ! | | ! |
| Treatment
| | '''ACC/AHA Guideline Recommendations''' |
| |- | | |- |
| ! | | ! |
| Line 118: |
Line 62: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia lifestyle modification|Lifestyle Modification]] | | [[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]] |
| |- | | |- |
| ! | | ! |
| Line 124: |
Line 68: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia medical therapy|Medical Therapy]] | | [[ACC AHA guideline on the treatment of blood cholesterol|Treatment]] |
| |- | | |- |
| ! | | ! |
| Line 130: |
Line 74: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia primary prevention| Primary Prevention]] | | [[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]] |
| |- | | |- |
| ! | | ! |
|
| |
|
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia secondary prevention| Secondary Prevention]] | | [[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]] |
| |- | | |- |
| ! | | ! |
| Line 142: |
Line 86: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia future or investigational therapies|Future or Investigational Therapies]] | | [[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]] |
| |-
| |
| | |
| !
| |
| |- bgcolor="CadetBlue"
| |
| !
| |
| Landmark Trials
| |
| |- | | |- |
| ! | | ! |
|
| |
|
| | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| |- bgcolor="CadetBlue" | | [[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]] |
| !
| |
| Case Studies
| |
| |- | | |- |
| ! | | ! |
| Line 161: |
Line 98: |
| |- bgcolor="PaleTurquoise" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [[Hyperlipoproteinemia case study one|Case #1]] | | [[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]] |
| |- | | |- |
| ! | | ! |
| |- bgcolor="PaleGoldenrod "
| |
| !
| |
| {{PAGENAME}} On the Web
| |
| |-
| |
| !
| |
|
| |
|
| |- bgcolor="LightYellow" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most recent articles] | | [[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]] |
| |- | | |- |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| ! | | ! |
| [http://scholar.google.com/scholar?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=ps Most cited articles]
| |
| |-
| |
| !
| |
|
| |
|
| |- bgcolor="LightYellow" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review articles] | | [[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]] |
| |- | | |- |
| ! | | ! |
|
| |
|
| |- bgcolor="LightYellow" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:health_continuing_education&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col3&cd=2 CME Programs] | | [[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]] |
| |- | | |- |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| ! | | ! |
| [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint slides]
| |
| |-
| |
| !
| |
|
| |
|
| |- bgcolor="LightYellow" | | |- bgcolor="PaleTurquoise" |
| ! | | ! |
| [http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images] | | [[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]] |
| |- | | |- |
| ! | | ! |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| American Roentgen Ray Society Images of {{PAGENAME}}
| |
| :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} All Images]
| |
| :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} X-ray}}}} X-rays]
| |
| :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} Ultrasound}}}} Echo & Ultrasound]
| |
| :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} CT}}}} CT Images]
| |
| :[http://goldminer.arrs.org/search.php?query={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}} MRI}}}} MRI]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials at Clinical Trials.gov]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://www.nice.org.uk/search/guidancesearchresults.jsp?keywords={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchType=guidance NICE Guidance]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://www.cdc.gov/search.do?queryText={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&searchButton.x=33&searchButton.y=6&action=search CDC on {{PAGENAME}}]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the news]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Hyperlipoproteinemia}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Hyperlipoproteinemia]
| |
| |-
| |
| !
| |
|
| |
| |- bgcolor="LightYellow"
| |
| !
| |
| [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=QWo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+risk+score+OR+risk+calculator&btnG=Search Risk calculators and risk factors for {{PAGENAME}}]
| |
| |-
| |
| !
| |
|
| |
|
| |} | | |} |